Birth defects after exposure to efavirenz-based antiretroviral therapy at conception/first trimester of pregnancy: a multicohort analysis
- Martinez De Tejada Weber, Begona
- Gayet-Ageron, Angèle
- Winterfeld, Ursula
- Thorne, Claire
- Favarato, Graziella
- European Pregnancy and Paediatric HIV Cohort Collaboration Study Group
Publication date
January 2019
DOI Publisher
Ovid Technologies (Wolters Kluwer Health)Abstract
To investigate the association between efavirenz (EFV) use during conception or first trimester (T1) of pregnancy and the occurrence of birth defects
Add to ORKG